BCDA

Biocardia Inc

BCDA.US biocardia.com + Research + Basket
CIK 0000925741
Employees 17
Phone 650 226 0120
Fiscal year end December
IPO Mar 14, 2008
Address 320 Soquel Way, Sunnyvale, CA, United States, 94085
0.91
-0.01 (-0.92%)
USD · NASDAQ
52-week range
0.75
1.50
Trading at 22% of the 52-week range
Market Cap
13.95M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.18
Div. Yield
N/A
% Institutions
14.80%
% Insiders
17.93%

1 Year

-31.3%

3 Year

-85.0%

10 Year

-99.6%
Description

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also provides CardiALLO, an allogeneic mesenchymal stem cell therapy which is in phase II for ischemic heart failure; allogeneic cell therapy platform; and PulmALLO, an allogeneic mesenchymal stem cell therapy for acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; Heart3D for fusion imaging; and morph DNA and avance steerable introducers. It has a license and distribution agreement with Biomet Biologics, LLC. BioCardia, Inc. is based in Sunnyvale, California.

Actions

Add an action for BCDA.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Peter A. Altman Ph.D. CEO, President & Director 1967
Mr. David McClung Chief Financial Officer 1963
Mr. Edward M. Gillis Senior Vice President of Devices 1962
Ms. Miranda Peto Benvenuti Investor Relations Executive NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 21, 2026 Peter Altman N/A Purchase 400.00 $1.23 $492.00 SEC
Apr 20, 2026 Peter Altman N/A Purchase 600.00 $1.23 $738.00 SEC
Feb 04, 2026 Peter Altman N/A Purchase 5.00K $1.13 $5.65K SEC
Jan 21, 2026 Peter Altman N/A Purchase 300.00 $1.34 $402.00 SEC
Jan 20, 2026 Peter Altman N/A Purchase 600.00 $1.32 $792.00 SEC
Dec 17, 2025 Peter Altman N/A Purchase 900.00 $1.30 $1.17K SEC
Dec 16, 2025 Peter Altman N/A Purchase 200.00 $1.37 $274.00 SEC
Sep 19, 2025 Andrew Scott Blank N/A Purchase 288.00K $1.25 $360.00K SEC
Sep 19, 2025 Peter Altman N/A Purchase 48.00K $1.25 $60.00K SEC
Sep 19, 2025 Simon H Stertzer N/A Purchase 398.40K $1.25 $498.00K SEC
Aug 22, 2025 Peter Altman N/A Purchase 700.00 $1.83 $1.28K SEC
Aug 13, 2025 Peter Altman N/A Purchase 100.00 $1.83 $183.00 SEC
Aug 12, 2025 Peter Altman N/A Purchase 400.00 $1.75 $700.00 SEC
Aug 11, 2025 Peter Altman N/A Purchase 1.70K $1.76 $2.99K SEC
Jun 30, 2025 Andrew Scott Blank N/A Purchase 72.29K $2.08 $150.36K SEC
Jun 30, 2025 David Mcclung N/A Purchase 4.82K $2.08 $10.02K SEC
Jun 30, 2025 Peter Altman N/A Purchase 24.10K $2.08 $50.12K SEC
Jun 30, 2025 Simon H Stertzer N/A Purchase 72.29K $2.08 $150.36K SEC
May 30, 2025 Peter Altman N/A Purchase 100.00 $2.21 $221.00 SEC
May 22, 2025 Peter Altman N/A Purchase 700.00 $1.89 $1.32K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Citigroup Inc 397.59K Jun 30, 2026 2.63% $0.00 0.00%
CM Management, LLC 300.00K Jun 30, 2026 1.98% $0.24 130.77%
Vanguard Capital Management, LLC 124.59K Jun 30, 2026 0.82% $0.00 0.00%
Pingora Partners LLC 120.38K Jun 30, 2026 0.80% $0.09 236.84%
UBS Group AG 77.62K Jun 30, 2026 0.51% $0.00 0.00%
Geode Capital Management, LLC 66.66K Jun 30, 2026 0.44% $0.00 -29.30%
Vanguard Fiduciary Trust Co 66.27K Jun 30, 2026 0.44% $0.00 0.00%
Susquehanna International Group, LLP 38.81K Jun 30, 2026 0.26% $0.00 -0.05%
Brown Advisory Holdings Inc 35.54K Jun 30, 2026 0.23% $0.00 0.00%
Commonwealth Equity Services, LLC 23.38K Jun 30, 2026 0.15% $0.00 27.89%
Citadel Advisors Llc 22.96K Jun 30, 2026 0.15% $0.00 -63.78%
StoneX Group Inc 20.02K Jun 30, 2026 0.13% $0.00 0.00%
Wealth Enhancement Advisory Services, LLC 18.50K Jun 30, 2026 0.12% $0.00 0.00%
GSA Capital Partners LLP 12.86K Jun 30, 2026 0.09% $0.00 0.00%
Tower Research Capital LLC 3.19K Jun 30, 2026 0.02% $0.00 7.02%
Morgan Stanley - Brokerage Accounts 3.11K Jun 30, 2026 0.02% $0.00 0.00%
Allied Private Wealth LLC 1.45K Jun 30, 2026 0.01% $0.00 0.00%
Global Retirement Partners, LLC. 411.00 Jun 30, 2026 0.00% $0.00 0.00%
SBI Securities Co Ltd 9.00 Jun 30, 2026 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 1.00 Jun 30, 2026 0.00% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Abante Quant Value FI 72.54K 0.48% ▲ 86.60% Aug 31, 2026
2 Fidelity Extended Market Index 58.32K 0.39% ▲ 25.49% Aug 31, 2026
3 Vanguard MStar Total Stk Mkt Idx Invest 55.57K 0.37% ▲ 0.00% Sep 30, 2026
4 Fidelity Series Total Market Index 10.53K 0.07% ▲ 0.00% Aug 31, 2026
5 Fidelity Total Market Index 3.24K 0.02% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $13.95M
EBITDA: $-7.38M
PEG Ratio: $0.00
Book Value: $0.18
Earnings/Share: $-0.64
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -134.97%
ROE (TTM): -1,803.19%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Valuation Metrics

Enterprise Value: $9.83M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 15.14M
Shares Float: 12.26M
% Insiders: 17.93%
% Institutions: 14.80%
Shares Short: 678.40K
Shares Short (Prior Month): 619.16K
Short Ratio: 2.11
Short % Float: 5.11%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-505.00K
Gross Profit
subtotal
$-505.00K
SG&A
adjust
$-3.32M
R&D
adjust
$-4.96M
Operating Income
subtotal
$-8.28M
Other / Non-Operating Items
adjust
$50.00K
Net Income
subtotal
$-8.23M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BCDA.US!